Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Eyetech Pharmaceuticals Inc.(EYET)

 
123Jump Rating: - Long-Term Growth   Underwriters: Merrill Lynch & Co.
      Morgan Stanley Dean Witter
Status: Priced   Bear Stearns & Co. Inc.
 
Address: 3 Times Square, 2th Floor
 FiledDate: 09/12/2003
  New York,
    
  NY 10036
 Filed Price Range ($): $18.00-20.00
       
Telephone: 212- 824-3100 Filed Offer Amount ($ Million): $136.50
       
Fax: Shares Offered (Millions): 6
       
Websites: www.eyetech.com Shares Outstanding (Millions): 38.53
       
Management: David Guyer, CEO
 IPO Date: 01/29/2004
     
  Final Offer Price ($): $21.00
       
Industry: Pharmaceuticals Final Offer Size (Millions of Shares): 6.50
       
Employees: 129 Final Offer Amount ($ Million): $136.50
       
Competitors: Genentech, Inc.
 S-1 Forms:
  Novartis
    
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Investor Relations Corporate / History Profile Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
2000 0.00 12292 -12292 0.00 -11111 -5.49
2001 0.00 26495 -26495 0.00 -24680 -7.43
2002 0.00 44982 -44982 0.00 -43173 -13.06
2003 30343 59835 -29492 -1391 -29360 -9.25
*As of Period from Feb 9, 2000 to Dec 31, 2000
*As of Sept 30, 2003
 
 
© 1999-2008 123jump.com. All rights reserved